Can Menopause Cause Bone Pain & What to Do About It

Menopause can and frequently does cause bone and joint pain, driven primarily by the sharp decline in estrogen that accompanies the end of reproductive years. In a study of over 700 Chinese women aged 35 to 64, postmenopausal women reported significantly more musculoskeletal symptoms than premenopausal women, with roughly a third experiencing frequent lower back pain, a third reporting frequent knee pain, and about a quarter dealing with joint stiffness or swelling.¹ The connection between estrogen loss and skeletal discomfort is more complex than most people realize, involving not just weakening bones but also heightened inflammation, altered pain processing, and shifts in gut bacteria that feed back into bone health.

Why Estrogen Loss Hurts Your Bones

Estrogen does far more for your skeleton than most people appreciate. It actively keeps the cells that break down bone (osteoclasts) in check by promoting a protective protein called osteoprotegerin and suppressing a signal called RANKL that recruits new bone-destroying cells.² Estrogen also directly triggers the death of osteoclasts in a dose-dependent manner, essentially culling the cells that would otherwise eat away at bone tissue.³ When estrogen drops during menopause, both of these brakes come off at once.

Animal studies illustrate this vividly. In mice whose ovaries were removed to simulate menopause, RANKL expression in the cells lining bone surfaces jumped roughly threefold. When estrogen was replaced, RANKL fell back to normal levels.⁴ The result of all this unchecked bone breakdown is that the fastest bone loss happens in the first couple of years after menopause, with the spine losing density especially quickly because of its high proportion of the spongy, metabolically active type of bone tissue.⁵

This accelerated bone loss does not always hurt at first. Osteoporosis has been called the “silent thief” because it usually progresses without noticeable pain until a fracture occurs.⁶ But that label can be misleading. Even without an obvious fracture, the increased osteoclast activity lowers the local pH around bone tissue, which sensitizes nerve fibers embedded in bone. In older people with osteoporosis, the density of pain-sensing nerve fibers in bone actually increases, and these nerves become more reactive.⁶ So the process of bone loss itself can generate a deep, aching discomfort long before a bone breaks.

The Inflammation Factor

Estrogen is also a powerful anti-inflammatory agent in the body. It suppresses the production of several inflammatory molecules, including IL-1, IL-6, and TNF-α.⁷ When estrogen drops, these inflammatory signals surge. Measurements in postmenopausal women show that blood levels of IL-1β, IL-8, and TNF-α are significantly higher than in women who are still menstruating. In fact, IL-8 levels in menopausal women are comparable to levels seen in people with chronic inflammatory diseases.⁸

This matters for bone pain because those same inflammatory molecules do double duty. They stimulate osteoclasts to break down more bone, and they also directly sensitize pain receptors in and around bone tissue. It is a self-reinforcing loop: estrogen withdrawal drives inflammation, inflammation accelerates bone breakdown, and bone breakdown creates the acidic environment that makes nerve endings fire more easily. The result is that menopausal bone pain often feels diffuse and hard to pin down, more like a persistent ache than a sharp injury, because the inflammation is systemic rather than confined to one spot.

Where the Pain Tends to Show Up

Not all joints and bones are equally affected. In the study of Chinese women mentioned earlier, the most common complaints were lower back pain (reported frequently by about a third of women), knee pain (about 31%), neck pain (about 30%), and pain at other joint sites (about a quarter). Joint stiffness and hand swelling were also common. Notably, the prevalence of all these symptoms peaked during early postmenopause, not late postmenopause, suggesting the transition period itself is the most painful phase rather than the years that follow it.¹

The spine is especially vulnerable because it contains a high percentage of trabecular bone, the lattice-like, fast-metabolizing type that estrogen loss hits hardest. The lower back pain many menopausal women describe may partly reflect microscopic structural changes in the vertebrae that never reach the threshold of an outright fracture but still generate nerve irritation. Knees and hands, meanwhile, are likely affected by the inflammatory component as much as by direct bone loss, since the soft tissues around these joints are rich in estrogen receptors.

How Pain Perception Itself Changes

Beyond the direct effects on bones and joints, menopause also rewires how the brain processes pain signals. Estrogen interacts with the nervous system, immune system, and stress-response pathways all at once. When it drops, these systems lose their dampening influence. Research describes a bidirectional relationship in which estrogen-related changes interact with musculoskeletal degeneration, immune sensitization, and stress responses to collectively amplify both the perception and the persistence of pain.⁹

This helps explain something that frustrates many women at midlife: imaging might show only mild osteopenia, yet the pain feels real and significant. The disconnect is not imaginary. When the pain-processing system becomes more sensitive, even modest structural changes can generate outsized discomfort. Sleep disruption, which is extremely common during menopause, feeds into this cycle as well, since poor sleep is one of the most reliable amplifiers of chronic pain. The overall picture is that menopausal bone pain is almost never purely skeletal. It is a whole-system event that involves bones, inflammation, nerves, and sleep.

Conditions That Mimic or Worsen Menopausal Bone Pain

Not all bone pain around menopause is caused by estrogen loss alone. Vitamin D deficiency and osteomalacia (a disorder in which bones fail to mineralize properly) overlap heavily with the menopausal window and can amplify or mimic the symptoms of postmenopausal bone loss. In one study of perimenopausal women, about 71% were deficient in vitamin D, and nearly half met the biochemical criteria for osteomalacia.¹⁰ Osteomalacia produces diffuse bone pain and tenderness that can feel very similar to postmenopausal bone loss, but it responds to vitamin D and mineral supplementation rather than to the treatments used for osteoporosis.

This is an important distinction because treating the wrong condition wastes time. If bone pain is driven by severe vitamin D deficiency, no amount of bisphosphonate therapy or exercise will fully resolve it. A blood test checking vitamin D, calcium, phosphorus, and alkaline phosphatase can usually sort this out. The same study found that low phosphorus, elevated alkaline phosphatase, and vitamin D deficiency were the strongest independent predictors of biochemical osteomalacia in perimenopausal women.¹⁰ Given how common vitamin D deficiency is in this population, checking these levels is one of the first things to do before assuming all bone pain is hormonal.

Hormone Therapy and Joint Pain

Because estrogen loss is the root driver, replacing estrogen is one of the most direct ways to address menopausal bone pain. Data from the Women’s Health Initiative, which enrolled thousands of postmenopausal women, showed that women randomly assigned to estrogen alone had significantly less joint pain after one year compared with those receiving a placebo.¹¹ The difference was statistically meaningful, though modest in absolute terms. Even low and ultra-low estrogen doses have been shown to help prevent bone loss while causing fewer side effects than standard doses.¹²

Hormone therapy is not a first-line treatment for osteoporosis prevention on its own, and it is not right for everyone. The decision involves weighing cardiovascular risks, breast cancer risk, and other factors with your doctor. But for women in early menopause who are dealing with hot flashes, sleep disruption, and bone pain all at once, hormone therapy can address multiple symptoms simultaneously, which is part of its appeal.

Prescription Medications for Bone Loss

When osteoporosis has already been diagnosed or bone loss is advancing despite lifestyle measures, targeted bone medications come into play. One of the most studied is denosumab, an injectable drug that works by blocking RANKL, the same bone-breakdown signal that estrogen normally suppresses. In a large trial, denosumab reduced the risk of new spine fractures by about 68%, hip fractures by about 40%, and other fractures by about 20% compared with placebo over three years.¹³ It also produced a greater increase in bone density and a larger drop in bone-breakdown markers than alendronate, one of the most commonly prescribed oral bisphosphonates.¹⁴

Selective estrogen receptor modulators, or SERMs, are another class of drugs that act on estrogen receptors in bone without the full systemic effects of hormone therapy. Raloxifene reduces the risk of vertebral fractures and, in higher-risk patients, non-spine fractures as well.¹⁵ Newer SERMs like lasofoxifene have shown improved skeletal effectiveness compared with raloxifene in trials and can prevent both vertebral and non-vertebral fractures.¹⁶ These medications primarily prevent fractures rather than directly relieving day-to-day bone pain, but by slowing the rate of bone destruction they reduce the nerve-sensitizing acid environment and inflammatory signals that drive ongoing discomfort.

Exercise and Physical Loading

Weight-bearing exercise is consistently recommended for postmenopausal bone health, though the evidence on exactly how much bone density it can rescue is more nuanced than headlines suggest. A 24-week study of postmenopausal women with low bone density found that high-impact aerobic dance improved bone mineral density at the femoral neck, along with grip strength and reaction time.¹⁷ However, an eight-month jumping exercise program showed only a small, non-significant trend toward improved bone in postmenopausal women, partly because the powerful bone-depleting effect of estrogen loss may overwhelm the bone-building stimulus of moderate exercise.¹⁸

Where exercise shines more clearly is in quality of life and pain. A three-month resistance and weight-bearing training program in postmenopausal women with low bone mass increased a marker of new bone formation without significantly raising the marker of bone breakdown, and significantly improved participants’ quality-of-life scores for pain, physical function, and overall wellbeing.¹⁹ In other words, even when exercise does not dramatically reverse bone loss, it can still meaningfully reduce pain and improve how you feel. Strength training, walking, dancing, and stair climbing are all reasonable options. The key is consistent loading over months, not a single intense bout.

Calcium, Vitamin D, and Soy Isoflavones

Calcium and vitamin D supplementation remains a straightforward and well-supported baseline strategy for slowing postmenopausal bone loss. A double-blind, randomized trial found that supplementation improved bone mineral density and bone mineral content in both peri- and postmenopausal women.²⁰ This is especially important given the high rates of vitamin D deficiency among perimenopausal women noted earlier.

Soy isoflavones, plant compounds that weakly mimic estrogen, have attracted attention as a dietary approach to menopausal bone loss. A meta-analysis of randomized trials found that consuming isoflavones led to a significant increase in spine bone density compared with not consuming them, with the effect becoming more pronounced at doses above 90 mg per day and appearing within six months.²¹ However, a well-designed two-year randomized trial found no significant differences in spine, hip, or femoral neck bone density between women taking soy isoflavones and those taking a placebo.²² The evidence is genuinely mixed. There may be a modest protective effect on the spine in the short term, but the long-term bone benefits of isoflavones are less certain. Some research does suggest isoflavones can reduce joint pain and markers of cartilage breakdown, so there may be a pain benefit even without large bone density gains.⁵

The Gut Microbiome Connection

One of the more surprising developments in bone research over the past decade is the discovery that the gut plays a meaningful role in postmenopausal bone loss. When estrogen drops, the composition of gut bacteria changes. In postmenopausal women, gut microbial diversity declines, and the barrier lining the intestine becomes more permeable, allowing bacterial products to leak into the bloodstream and trigger low-grade inflammation.²³ This gut-driven inflammation adds to the inflammatory burden already created by estrogen withdrawal and further accelerates bone breakdown.²⁴

Animal experiments make the link even more compelling. When gut bacteria were depleted with antibiotics in mice whose ovaries had been removed, bone mass, bone structure, and bone strength all improved. Conversely, transplanting the gut bacteria from estrogen-deficient mice into healthy mice was enough to trigger bone loss on its own.²⁵ Obviously, wiping out gut bacteria with antibiotics is not a practical treatment for humans, but these findings suggest that interventions targeting gut health, like probiotics, fermented foods, and dietary fiber, could eventually become part of the toolkit for managing postmenopausal bone loss. The research is still in early stages, but the mechanistic evidence is strong enough that this area deserves attention.

Acupuncture as an Add-On Therapy

For women looking beyond conventional medicine, acupuncture has accumulated a growing evidence base as a complement to standard osteoporosis treatments. A systematic review and meta-analysis of randomized controlled trials found that acupuncture significantly improved bone mineral density across multiple skeletal sites, with particularly strong results in postmenopausal women with osteoporosis. Pain scores and symptom assessments also improved, and adverse events were lower in the acupuncture groups.²⁶

A network meta-analysis that compared different forms of acupuncture found that electroacupuncture combined with standard medication was the most effective for overall results and lumbar spine density, while other techniques like moxibustion and acupoint catgut embedding excelled at different outcomes such as femoral neck density and pain reduction.²⁷ The important detail here is that acupuncture performed best as an add-on to conventional treatment, not as a replacement for it. If you are already taking medication and doing weight-bearing exercise, adding acupuncture sessions may provide additional pain relief and possibly further bone density gains.

When to Get Tested and What to Ask For

If you are experiencing persistent bone or joint pain during the menopausal transition, a few straightforward tests can clarify what is going on. A DEXA scan (dual-energy X-ray absorptiometry) is the standard tool for measuring bone density and diagnosing osteoporosis or its milder precursor, osteopenia.²⁸ Blood tests for vitamin D, calcium, phosphorus, and alkaline phosphatase can rule out or confirm osteomalacia. Thyroid function and parathyroid hormone levels are also worth checking, since overactive parathyroid glands can cause bone pain and accelerated bone loss that mimics postmenopausal osteoporosis.

Many women hesitate to bring up diffuse bone aching with their doctor because it feels vague or hard to describe. But the combination of menopausal timing and widespread skeletal discomfort is a recognizable clinical pattern. The sooner the underlying cause is identified, the more options are available, since bone loss that has been progressing for years is harder to reverse than loss caught early. If your doctor’s initial response is to attribute everything to “normal aging,” it is worth asking specifically about DEXA screening, vitamin D testing, and whether hormone therapy or other bone-protective medication might be appropriate for your risk profile.